Quality of transurethral resection of bladder tumour documentation: implications for non‐muscle‐invasive bladder cancer risk stratification and management
BJU International · 2024
DOI: 10.1111/bju.16273 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJU International, 2024. Verfasst von Abram Botros und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Eastern Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Urology, Eastern Health, Melbourne, Victoria, Australia.
- Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
- Department of Oncology, Eastern Health, Melbourne, Victoria, Australia.
ORCID-Profile: Abram Botros, Paul M Rival, Shomik Sengupta
Zitieren
APA
Botros, A., Rival, P. M., Page, F., Davis, I. D., & Sengupta, S. (2024). Quality of transurethral resection of bladder tumour documentation: implications for non‐muscle‐invasive bladder cancer risk stratification and management. BJU International. https://doi.org/10.1111/bju.16273
Vancouver
Botros A, Rival PM, Page F, Davis ID, Sengupta S. Quality of transurethral resection of bladder tumour documentation: implications for non‐muscle‐invasive bladder cancer risk stratification and management. BJU International. 2024. doi:10.1111/bju.16273
BibTeX
@article{Botros2024,
author = {Botros, Abram and Rival, Paul M and Page, Fiona and Davis, Ian D and Sengupta, Shomik},
title = {Quality of transurethral resection of bladder tumour documentation: implications for non‐muscle‐invasive bladder cancer risk stratification and management},
journal = {BJU International},
year = {2024},
doi = {10.1111/bju.16273}
}
EUVIMED